Protagonist Therapeutics (PTGX)

• Market cap: $5.51B
• 1 day: 1.86%
• 5 days: 8.1%
• 1 month: 7.17%
• 3 months: 0.58%
• 6 months: 55.06%
• Year to date: 1.17%
• 1 year: 145%
• 5 years: 248.48%
• 10 years: 653.85%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Employees: 128